164 related articles for article (PubMed ID: 31484389)
1. Increased Efficacy of Oral Fixed-Dose Combination of Amphotericin B and AHCC
Pérez-Cantero A; Serrano DR; Navarro-Rodríguez P; Schätzlein AG; Uchegbu IF; Torrado JJ; Capilla J
Pharmaceutics; 2019 Sep; 11(9):. PubMed ID: 31484389
[TBL] [Abstract][Full Text] [Related]
2. AHCC
Park HJ; Boo S; Park I; Shin MS; Takahashi T; Takanari J; Homma K; Kang I
Front Immunol; 2022; 13():875872. PubMed ID: 35514996
[TBL] [Abstract][Full Text] [Related]
3. Efficacy, Biodistribution, and Nephrotoxicity of Experimental Amphotericin B-Deoxycholate Formulations for Pulmonary Aspergillosis.
López-Sánchez A; Pérez-Cantero A; Torrado-Salmerón C; Martin-Vicente A; García-Herrero V; González-Nicolás MÁ; Lázaro A; Tejedor A; Torrado-Santiago S; García-Rodríguez JJ; Capilla J; Torrado S
Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29760126
[TBL] [Abstract][Full Text] [Related]
4. The Tumor Growth Inhibitory Effect of a Standardized Extract of Cultured Lentinula edodes Mycelia Using Patient Derived Xenograft Model.
Yoshii R; Adachi S; Ryo H; Hatanaka E; Yasuda K; Kaji M; Enomoto K; Takanari J; Yoshidome K; Nomura T; Tomiyama N
Biol Pharm Bull; 2024; 47(2):532-538. PubMed ID: 38417905
[TBL] [Abstract][Full Text] [Related]
5. Comparative study on the efficacy of liposomal amphotericin B and voriconazole in a murine pulmonary aspergillosis model.
Takemoto K; Yamamoto Y; Ueda Y; Kanazawa K; Yoshida K; Niki Y
Chemotherapy; 2009; 55(2):105-13. PubMed ID: 19151551
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of aerosolized liposomal amphotericin B against murine invasive pulmonary mucormycosis.
Mihara T; Kakeya H; Izumikawa K; Obata Y; Nishino T; Takazono T; Kosai K; Morinaga Y; Kurihara S; Nakamura S; Imamura Y; Miyazaki T; Tsukamoto M; Yamamoto Y; Yanagihara K; Tashiro T; Kohno S
J Infect Chemother; 2014 Feb; 20(2):104-8. PubMed ID: 24462443
[TBL] [Abstract][Full Text] [Related]
7. Comparative analysis of amphotericin B lipid complex and liposomal amphotericin B kinetics of lung accumulation and fungal clearance in a murine model of acute invasive pulmonary aspergillosis.
Lewis RE; Liao G; Hou J; Chamilos G; Prince RA; Kontoyiannis DP
Antimicrob Agents Chemother; 2007 Apr; 51(4):1253-8. PubMed ID: 17261624
[TBL] [Abstract][Full Text] [Related]
8. Long-circulating immunoliposomal amphotericin B against invasive pulmonary aspergillosis in mice.
Otsubo T; Maruyama K; Maesaki S; Miyazaki Y; Tanaka E; Takizawa T; Moribe K; Tomono K; Tashiro T; Kohno S
Antimicrob Agents Chemother; 1998 Jan; 42(1):40-4. PubMed ID: 9449258
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of amphotericin B or amphotericin B-intralipid in combination with caspofungin against experimental aspergillosis.
Sionov E; Mendlovic S; Segal E
J Infect; 2006 Aug; 53(2):131-9. PubMed ID: 16360214
[TBL] [Abstract][Full Text] [Related]
10. Amphotericin B and its new formulations: pharmacologic characteristics, clinical efficacy, and tolerability.
Tiphine M; Letscher-Bru V; Herbrecht R
Transpl Infect Dis; 1999 Dec; 1(4):273-83. PubMed ID: 11428998
[TBL] [Abstract][Full Text] [Related]
11. Comparative efficacies, toxicities, and tissue concentrations of amphotericin B lipid formulations in a murine pulmonary aspergillosis model.
Olson JA; Adler-Moore JP; Schwartz J; Jensen GM; Proffitt RT
Antimicrob Agents Chemother; 2006 Jun; 50(6):2122-31. PubMed ID: 16723574
[TBL] [Abstract][Full Text] [Related]
12. Oral Supplementation with AHCC
Singh A; Adam A; Rodriguez L; Peng BH; Wang B; Xie X; Shi PY; Homma K; Wang T
Pathogens; 2023 Apr; 12(4):. PubMed ID: 37111440
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of high loading doses of liposomal amphotericin B in the treatment of experimental invasive pulmonary aspergillosis.
Gavaldà J; Martín T; López P; Gomis X; Ramírez JL; Rodríguez D; Len O; Puigfel Y; Ruiz I; Pahissa A
Clin Microbiol Infect; 2005 Dec; 11(12):999-1004. PubMed ID: 16307554
[TBL] [Abstract][Full Text] [Related]
14. Activation of NF-E2 p45-related factor-2 transcription and inhibition of intestinal tumor development by AHCC, a standardized extract of cultured
Takahashi M; Fujii G; Hamoya T; Kurokawa Y; Matsuzawa Y; Miki K; Komiya M; Narita T; Mutoh M
J Clin Biochem Nutr; 2019 Nov; 65(3):203-208. PubMed ID: 31777421
[TBL] [Abstract][Full Text] [Related]
15.
Seyedmousavi S; Mouton JW; Melchers WJG; Verweij PE
Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28416540
[TBL] [Abstract][Full Text] [Related]
16. The Effects of AHCC®, a Standardized Extract of Cultured
Shin MS; Park HJ; Maeda T; Nishioka H; Fujii H; Kang I
J Immunol Res; 2019; 2019():3758576. PubMed ID: 31930148
[TBL] [Abstract][Full Text] [Related]
17. A standardized extract of cultured
Islam S; Kitagawa T; Baron B; Kuhara K; Nagayasu H; Kobayashi M; Chiba I; Kuramitsu Y
Oncol Lett; 2021 Sep; 22(3):654. PubMed ID: 34386076
[TBL] [Abstract][Full Text] [Related]
18. A Standardized Extract of Cultured
Kitagawa T; Islam S; Baron B; Tokuda K; Paudel D; Ohta T; Nakagawa K; Kobayashi M; Okada F; Kuramitsu Y
Anticancer Res; 2023 Mar; 43(3):1239-1244. PubMed ID: 36854525
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of
Yanagimoto H; Hirooka S; Yamamoto T; Yamaki S; Sekimoto M
Nutr Cancer; 2023; 75(1):236-246. PubMed ID: 35950537
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic and hemolytic evaluation of in-situ liposomal preparation containing amphotericin - beta complexed with different chemically modified beta - cyclodextrins.
Chakraborty KK; Naik SR
J Pharm Pharm Sci; 2003; 6(2):231-7. PubMed ID: 12935435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
